Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Integra LifeSciences Holdings Corp (Integra) is a medical technology company that offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.
Integra LifeSciences Holdings Corp Key Recent Developments
Apr 28,2021: Integra LifeSciences Reports First Quarter 2021 Financial Results
Apr 08,2021: Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
Apr 01,2021: Integra LifeSciences Appoints Shaundra Clay as Director
Feb 18,2021: Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
Jan 14,2021: Integra LifeSciences announces preliminary fourth quarter and full-year 2020 revenue results; will host fourth quarter financial results conference call on February 18, 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Integra LifeSciences Holdings Corp (Integra) is a medical technology company that offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.
Integra LifeSciences Holdings Corp Key Recent Developments
Apr 28,2021: Integra LifeSciences Reports First Quarter 2021 Financial Results
Apr 08,2021: Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
Apr 01,2021: Integra LifeSciences Appoints Shaundra Clay as Director
Feb 18,2021: Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
Jan 14,2021: Integra LifeSciences announces preliminary fourth quarter and full-year 2020 revenue results; will host fourth quarter financial results conference call on February 18, 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Integra LifeSciences Holdings Corp - Key Facts
Integra LifeSciences Holdings Corp - Key Employees
Integra LifeSciences Holdings Corp - Key Employee Biographies
Integra LifeSciences Holdings Corp - Major Products and Services
Integra LifeSciences Holdings Corp - History
Integra LifeSciences Holdings Corp - Company Statement
Integra LifeSciences Holdings Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Integra LifeSciences Holdings Corp - Business Description
Business Segment: Codman Specialty Surgical
Overview
Performance
Business Segment: Orthopedics and Tissue Technologies
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Integra LifeSciences Holdings Corp - Corporate Strategy
Integra LifeSciences Holdings Corp - SWOT Analysis
SWOT Analysis - Overview
Integra LifeSciences Holdings Corp - Strengths
Integra LifeSciences Holdings Corp - Weaknesses
Integra LifeSciences Holdings Corp - Opportunities
Integra LifeSciences Holdings Corp - Threats
Integra LifeSciences Holdings Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 28, 2021: Integra LifeSciences Reports First Quarter 2021 Financial Results
Apr 08, 2021: Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
Apr 01, 2021: Integra LifeSciences Appoints Shaundra Clay as Director
Feb 18, 2021: Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
Jan 14, 2021: Integra LifeSciences announces preliminary fourth quarter and full-year 2020 revenue results; will host fourth quarter financial results conference call on February 18, 2021
Jan 14, 2021: Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2020 Revenue Results; Will Host Fourth Quarter Financial Results Conference Call on February 18, 2021
Dec 15, 2020: Integra LifeSciences selects Veeva Vault CDMS for clinical data management
Oct 28, 2020: Integra LifeSciences reports third quarter 2020 financial results
Sep 30, 2020: Smith+Nephew to acquire Integra LifeSciences’ extremity Orthopedics
Aug 10, 2020: Integra LifeSciences reports second quarter 2020 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Integra LifeSciences Holdings Corp - Key Facts
Integra LifeSciences Holdings Corp - Key Employees
Integra LifeSciences Holdings Corp - Key Employee Biographies
Integra LifeSciences Holdings Corp - Major Products and Services
Integra LifeSciences Holdings Corp - History
Integra LifeSciences Holdings Corp - Company Statement
Integra LifeSciences Holdings Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Integra LifeSciences Holdings Corp - Business Description
Business Segment: Codman Specialty Surgical
Overview
Performance
Business Segment: Orthopedics and Tissue Technologies
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Integra LifeSciences Holdings Corp - Corporate Strategy
Integra LifeSciences Holdings Corp - SWOT Analysis
SWOT Analysis - Overview
Integra LifeSciences Holdings Corp - Strengths
Integra LifeSciences Holdings Corp - Weaknesses
Integra LifeSciences Holdings Corp - Opportunities
Integra LifeSciences Holdings Corp - Threats
Integra LifeSciences Holdings Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 28, 2021: Integra LifeSciences Reports First Quarter 2021 Financial Results
Apr 08, 2021: Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
Apr 01, 2021: Integra LifeSciences Appoints Shaundra Clay as Director
Feb 18, 2021: Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
Jan 14, 2021: Integra LifeSciences announces preliminary fourth quarter and full-year 2020 revenue results; will host fourth quarter financial results conference call on February 18, 2021
Jan 14, 2021: Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2020 Revenue Results; Will Host Fourth Quarter Financial Results Conference Call on February 18, 2021
Dec 15, 2020: Integra LifeSciences selects Veeva Vault CDMS for clinical data management
Oct 28, 2020: Integra LifeSciences reports third quarter 2020 financial results
Sep 30, 2020: Smith+Nephew to acquire Integra LifeSciences’ extremity Orthopedics
Aug 10, 2020: Integra LifeSciences reports second quarter 2020 financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Integra LifeSciences Holdings Corp, Performance Chart (2016 - 2020)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Performance Chart (2016 - 2020)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021